<DOC>
	<DOCNO>NCT02505867</DOCNO>
	<brief_summary>The purpose study evaluate effect in-hospital diagnosis treatment sleep disorder breathing ( SDB ) post-discharge mortality readmission in- hospitalized patient acute heart failure syndrome reduce ejection fraction ( HFrEF ) .</brief_summary>
	<brief_title>The Role Sleep Disordered Breathing Heart Failure Admissions</brief_title>
	<detailed_description>The purpose study evaluate effect in-hospital diagnosis treatment sleep disorder breathing ( SDB ) post-discharge mortality readmission in- hospitalized patient heart failure reduce ejection fraction ( HFrEF ) . The study randomize control trial HFrEF patient hospitalize acute heart failure syndrome ( AHFS ) in-hospital sleep study diagnostic SDB . Participants randomize either current standard care AHFS treatment intervention arm expedite treatment adaptive servo ventilation initiate immediately upon in-hospital diagnosis SDB .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<criteria>1 . Admission diagnosis heart failure AHFS define follow : A chief complaint dyspnea fatigue ; elevate leave ventricular pressure . Elevated leave ventricular pressure indicate least one following : sign volume overload pedal edema , crackle , consistent chest Xray , increase measurement leave ventricular enddiastolic diameter volume , elevate BNP level . 2 . Previously unrecognized recognize untreated SDB diagnose confirm attended inpatient sleep study index hospitalization AHFS . SDB define one follow syndrome : 1 . AHI &gt; 15 50 % apneas central ( CSA ) ; 2 . AHI &gt; 30 event 50 % event obstructive ( severe OSA ) patient LVEF &lt; 30 % . 3 . Projected length stay &gt; 2 day admission day ensure uniformity underlie severity AHFS enable introduction ASV device education 4 . LVEF &lt; 45 % within 1 year admission . An echocardiogram may perform confirm LVEF hospitalization determine eligibility . 5 . Ongoing target treatment heart failure current hospitalization include least one following : IV diuretic , IV infusion inotropes vasodilator , plan revascularization , device therapy . Exclusion criterion : 1 . Patients supplemental oxygen indication SDB heart failure prior admission . These patient chronic respiratory insufficiency . 2 . Patients treatment target CSA OSA ( ASV , oxygen , CPAP ) ; patient already provide reject positive airway pressure therapy due intolerance pressure claustrophobia . 3 . Cardiogenic shock hemodynamic instability MAP le 55 mmHg vasopressor , concurrently vasopressor treatment , leave ventricular assist device , intraaortic Balloon Pump . Inotropic agent constitute exclusion criterion . Patients eligible stable vasopressor . 4 . Acute respiratory failure insufficiency define ( PaO2/FIO2 ) ratio less 250 , FIO2 requirement 40 % . Patients eligible participate FIO2 requirement 30 % . 5 . Overt neurological deficit patient arrive longterm care facility expect discharged one ; patient poor functional outcome preclude ability use ASV device independently 6 . Renal failure require renal replacement therapy ; Patients exclude undergoing ultrafiltration volume removal . 7 . Moderate severe chronic obstructive lung disease ( FEV1/FVC &lt; 55 % ) . 8 . Patients likely receive heart transplant leave ventricular assist device ( LVAD ) subsequent year . These patient high stand transplant list index hospitalization cardiothoracic evaluation implantation LVAD . 9 . Patients long term `` bridging '' inotropic infusion , short life expectancy due concomitant illness heart failure 10 . Patients report severe sleepiness consider risk driving . 11 . Patients fail secondary screening procedure . Secondary screening procedure involve patient ask wear device experience pressure delivery least 30 minute relax .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>